New insights into the diagnosis and treatment of neurotrophic keratopathy

Ocular Surface

Volumn 3, Issue 2, 2005, Pages 96-110

  Goins, Kenneth Mark ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Corneal nerves; Corneal wound healing; Diabetes mellitus; Dry eye syndrome; Familial dysautonomia; Gasserian ganglion; Herpes simplex; Herpes zoster ophthalmicus; Ocular surgery; Substance P

Indexed keywords

ACETYLCHOLINE; ACETYLCYSTEINE; ALDOSE REDUCTASE INHIBITOR; ANESTHETIC AGENT; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CARBONATE DEHYDRATASE INHIBITOR; CORTICOSTEROID; CYANOACRYLATE; DOXYCYCLINE; EPIDERMAL GROWTH FACTOR; FIBRIN GLUE; LUBRICATING AGENT; MEDROXYPROGESTERONE; NERVE GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; POLYTRIM; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SCOPOLAMINE; TETRACYCLINE; THIAMINE;

AGING; AUTONOMIC NEUROPATHY; BIOMICROSCOPY; CENTRAL NERVOUS SYSTEM DISEASE; CONFOCAL MICROSCOPY; CORNEA EPITHELIUM; CORNEA PERFORATION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DRUG COST; DRUG MECHANISM; EYE PAIN; EYE SURGERY; GASTROINTESTINAL SYMPTOM; HARD CONTACT LENS; HUMAN; HYPEREMIA; HYPERTENSION; INFERTILITY; KERATOPATHY; NERVE STIMULATION; NEUROTROPHIC KERATOPATHY; PATHOGENESIS; PHOTOSENSITIVITY DISORDER; PROTECTIVE EQUIPMENT; REVIEW; SCHIRMER TEST; SECONDARY GLAUCOMA; SENSORY STIMULATION; SLIT LAMP; SOFT CONTACT LENS; TEAR FILM; TREATMENT INDICATION; TRIGEMINAL NERVE DISEASE; UVEITIS; VAGINITIS; VISUAL DISORDER; WOUND HEALING;

EID: 20144372415     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70158-1     Document Type: Article

References (150)

1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001;79:214-22
2. Davis EA, Dohlman CH. Neurotrophic keratitis. Int Ophthalmol Clin 2001;41:1-11
3. Magendie M. Del'influence de la cinqieme paire de nerfs sur la nutrition et les functions del'oeil. J Physiol 1824;4:176-82
4. Zamir E, Chowers I, Banin E, Frucht-Pery J. Neurotrophic corneal endothelial failure complicating acute Horner syndrome. Ophthalmology 1999;106:1692-6
5. Nagano T, Nakamura M, Nakata K, et al. Effects of substance P and ICF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. Invest Ophthalmol Vis Sci 2003;44:3810-5
6. Nakamura M, Kawahara M, Nakata K, Nishida T. Restoration of corneal epithelial barrier function and wound healing by substance P and IGF-1 in rats with capsaicin-induced neurotrophic keratopathy. Invest Ophthalmol Vis Sci 2003;44:2937-40
7. Cavanagh HD, Colley AM. The molecular basis of neurotrophic keratitis. Acta Ophthalmol Suppl 1989; 192:115-134
8. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea 2001;20:1-13
9. Cobo LM. Corneal complications of herpes zoster ophthalmicus: prevention and treatment. Cornea 1988;7:50-6
10. Severson EA, Baratz KH, Hodge DO Burke JP. Herpes zoster ophthalmicus in Olmsted County, Minnesota - have systemic antivirals made a difference? Arch Ophthalmol 2003;121:386-90
11. Ruben ST. Corneal sensation in insulin dependent and noninsulin dependent diabetics with proliferative retinopathy. Acta Ophthalmol (Copenh) 1994; 72(5):576-80
12. Foulks GN, Thoft RA, Perry HD, Tolentino FI. Factors related to corneal epithelial complications after closed vitrectomy in diabetics. Arch Ophthalmol 1979; 97:1076-8
13. Goebbels M. Tear secretion and tear film function in insulin-dependent diabetics. Br J Ophthalmol 2000; 84:19-21
14. Hyndiuk RA, Kazarian EL, Schultz, RO, Seideman S. Neurotrophic corneal ulcers in diabetes mellitus. Arch Ophthalmol 1977; 95:2193-6
15. Schwartz DE. Corneal sensitivity in diabetics. Arch Ophthalmol 1974; 91:174-8
16. Stolwijk TR, van Best JA, BoorJP, et al. Corneal epithelial barrier function after oxybuprocanine provocation in diabetes. Invest Ophthalmol Vis Sci 1990; 31:436-9
17. Hosotani, H, Ohashi Y, Yamada M, Tsubota, K. Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112. AmJ Ophthalmol 1995;119:288-94
18. Fujishima H, Shimazaki J, Yagi Y, Tsubota K. Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: a preliminary study. Cornea 1996;15:368-75
19. Hietaharju A, Yli-Kerttula U, Hakkinen V, Frey H. Nervous system manifestations in Sjogren's syndrome. Acta Neurol Scand 1990;81:144-52
20. Tajima Y, Mito Y, Owada Y, et al. Neurological manifestations of primary Sjogren's syndrome in Japanese patients. Intern Med 1997; 36:690-3
21. Mellgren SI, Conn DL, Stevens JC, Dyck PJ. Peripheral neuropathy in primary Sjogren's syndrome. Neurology 1989;39:390-4
22. Griffin JW, Cornblath DR, Alexander E, et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Ann Neurol 1990; 27:304-15
23. Valls-Sole J, Graus F, Font J, et al. Normal proprioceptive trigeminal afferents in patients with Sjogren's syndrome and sensory neuropathy. Ann Neurol 1990; 28:786-90
24. Tuominen IS, Konttinen YT, Vesaluoma MH, et al. Corneal innervation and morphology in primary Sjogren's syndrome. Invest Ophthalmol Vis Sci 2003; 44:2545-9
25. Benitez del Castillo JM, Wasfy MAS, Fernandez C, Garcia-Sanchez J. An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci 2004;45:3030-5
26. Gupta A, Heigle T, Pflugfelder SC. Nasolacrimal stimulation of aqueous tear production. Cornea 1997;16:645-8
27. Sadanaga M. Clinical evaluation of vidian neurectomy. Auris Nasus Larynx 1989; 16(Suppl 1):S53-7
28. Krant JN, Wildervanck de Blecourt P, Dieges PH, de Heer LJ. Long-term results of Vidian neurectomy. Rhinology 1979;17:231-5
29. Lin PY, Cheng CY, Wu CC, et al. Bilateral neurotrophic keratopathy complicating vidian neurectomy. Am J Ophthalmol 2001;132:106-8
30. Heigle TJ, Pflugfelder SC. Aqueous tear production in patients with neurotrophic keratitis. Cornea 1996;15:135-8
31. Goldberg MF, Payne J, Brunt PW. Ophthalmologic studies of familial dysautonomia. The Riley-Day syndrome. Arch Ophthalmol 1968;180:733
32. Jarade EF, El-Sheikh HF, Tabbara KF. Indolent corneal ulcers in a patient with congenital insensitivity to pain with anhidrosis: a case report and literature review. Eur J Ophthalmol 2002;12:60-5
33. Yagev R, Levy J, Shorer, Z, Lifshitz T. Congenital insensitivity to pain with anhidrosis: ocular and systemic manifestations. Am J Ophthalmol 1999;127:322-6
34. Donaghy M, Hakin R, Bamford JM, et al. Hereditary sensory neuropathy with neurotrophic keratitis. Description of an autosomal recessive disorder with a selective reduction of small myelinated nerve fibres and a discussion of the classification of the hereditary sensory neuropathies. Brain 1987; 110:563-83
35. Mohandessan MM, Romano PE. Neuroparalytic keratitis in Goldenhar-Gorlin syndrome. Am J Ophthalmol 1978; 85:111-3
36. Velasco MJ, Bermudez FJ, Romero J, Hita E. Variations in corneal sensitivity with hydrogel lenses. Acta Ophthalmol 1994; 72:53-6
37. Murphy PJ, Patel S, Marshall J. The effect of long-term, daily contact lens wear on corneal sensitivity. Cornea 2001;20:264-9
38. Millodot M. Effect of length of wear of contact lenses on corneal sensitivity. Acta Ophthalmol (Copenh) 1976;54:721-30
39. Bergenske PD, Polse KA.The effect of rigid gas permeable lenses on corneal sensitivity. J Am Optom Assoc 1987; 58:212-5
40. Cantullera JA. Injury to the skull and face associated with neuroparalytic keratitis. Rev espan Oto-Neuro-Oftal y Neurocir 1947;6:247-52
41. Cantullera JA. Craniofacial trauma with neuro-paralytic keratitis, Arch Soc Oftal Hisp-Amer 1947; 7:661-70
42. Fau R, Isnel R. Neuroparalytic keratitis occurring as a sequel to an old wound of the lower jaw. Soc Oto-Neuro-Ophtal 1948; 20:319-20
43. Sedan J. Neuroparalytic keratitis in a boxer, following repeated fractures of the mandible occurring at 5 years interval. Rev Oto-Neuro-Ophtal 1949; 21:498-501
44. Madhusudan GR, Sharma RK, Nanda V. Neuroparalytic keratitis: A rare manifestation of posttraumatic superior orbital fissure syndrome. Ann Plast Surg 2004; 53:83-5
45. Szerenyi K, Sorken K, Garbus JJ, et al. Decrease in normal human corneal sensitivity with topical diclofenac sodium. Am J Ophthalmol 1994; 118:312-5
46. Reviglio VE, Rana TS, Li QJ, effects of topical nonsteroidal anti-inflammatory drugs on the expression of matrix metalloproteinases in the cornea. J Cat Refract Surg 2003; 29(5):989-97
47. Rosenwasser GO: Complications of topical ocular anesthetics. Int Ophthalmol Clin 1989 Fall;29:153-8
48. Rosenwasser GO, Holland S, Pflugfelder SC: Topical anesthetic abuse. Ophthalmology 1990;97;967-72
49. Willis WE, Laibson PR: Corneal complications of topical anesthetic abuse. Can J Ophthalmol 1970;5:239-43
50. Spinelli D, Vigasio F, Montanari P. Short-term and long-term timolol maleate effects on corneal sensitivity. Doc Ophthalmol 1984;56:385-92
51. Weissman SS, Asbell PA. Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity. Br J Ophthalmol 1990;74:409-12
52. Van Buskirk EM. Adverse reactions from timolol administration. Ophthalmology 1980;87:447-50
53. Kohlhaas M, Mammen A, Richard G. [Change in corneal sensitivity after topical dorzolamide administration. A comparative study]. Ophthalmologe 1997;94:424-7
54. Chang FW, Reinhart S, Fraser NM. Effect of 30% sodium sulfacetamide on corneal sensitivity. Am J Optom Physiol Opt 1984;61:318-20
55. Reviglio VE, Hakim MA, Song JK, O'Brien TP. Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea. BMC Ophthalmol 2003;3:10-23
56. Mallari PL, Mccarty DJ, Daniell M, Taylor H. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol 2001;131:131-3
57. Muller LJ, Pels L, Vrensen GF. Ultrastructural organization of human corneal nerves. Invest Ophthalmol Vision Sci 1996;37:476-88
58. Lawrenson JG, Corbett MC, O'Brart DP, Marshall J. Effect of beam variables on corneal sensitivity after excimer laser photorefractive keratectomy. Br J Ophthalmol 1997;81):686-90
59. Chuck RS, Quiros PA, Perez AC, McDonnell PJ. Corneal sensation after laser in-situ keratomileusis. J Cataract Refract Surg 2000; 26:337-9
60. Donnenfeld, ED, Solomon K, Perry HD, et al. The effect of hinge position on corneal sensation and dry eye after LASIK. Ophthalmology 2003 110:1023-30
61. Kanellopoulos AJ, Pallikaris IG, Donnenfeld ED, et al. Comparison of corneal sensation following photorefractive keratotecomy and laser in-situ keratomileusis. J Cataract Refract Surg 1997;23:34-8
62. Rao GN, John T, Ishida N, Aquavella JV. Recovery of corneal sensitivity in grafts following penetrating keratoplasty. Ophthalmology 1985;92:1408-11
63. Gong XM. [Recovery of corneal sensitivity following keratoplasty and corneal disease's. Zhonghua Ya Ke Za Zhi 1992;28:150-2
64. Miele G, Gloor B. [Corneal ulcer after intraocular interventions and after cyclocryocoagulation]. Klin Monatsbl Augenheilkd 1995; 206:320-1
65. Johnson SM. Neurotrophic corneal defects after diode laser cycloablation. Am J Ophthalmol 1998;126:725-7
66. Groh MJ, Kuchle M, Naumann GO. Corneal neural paralysis after block excision including the 3 and 9 o'clock meridian. Ophthalmologe 2002;99:181-2
67. Chavanne H, Rougier J. Neuroparalytic keratitis after bulbar tractotomy, Bull Soc Ophtalmol Fr 1949;2:387-9
68. Zabel RW, Mintsioulis G. Hyperplastic precorneal membranes. Extending the spectrum of neurotrophic keratitis. Cornea 1989;8:247-50
69. Choudhury BK, Pahari S, Acharyya,A, et al. Percutaneous retrgasserian radiofrequency thermal rhizotomy for trigeminal neuralgia. J Indian Med Assoc 1991;89:294-6
70. Lewis RA, Keltner JL, Cobb CA. Corneal anesthesia after percutaneous radiofrequency trigeminal rhizotomy. A retrospective study. Arch Ophthalmol 1982; 100:301-3
71. Onofrio BM. Radiofrequency percutaneous Gasserian ganglion lesions. Results in 140 patients with trigeminal pain. J Neurosurg 1975;42:132-9
72. Ackermann-Korner M, Draeger J. [Quantitative determination of corneal sensitivity in idiopathic trigeminal neuralgia and after neurosurgical interventions on the trigeminal nerve]. Klin Monatsbl Augenheilkd 1991;199:84-90
73. Rosenstock TG, Hurwitz JJ, Nedzelski JM, Tator CH. Ocular complications following excision of cerebellopontine angle tumours. Can J Ophthalmol 1986;21:134-9
74. Lanigan DT, Romanchuk K, Olson CK. Ophthalmic complications associated with orthognathic surgery. J Oral Maxillofac Surg 1993;51:480-94
75. Millodot M. The influence of age on the sensitivity of the cornea. Invest Ophthalmol Vis Sci 1977;16:240-2
76. Kotulak JC, Brungardt T. Age-related changes in the cornea. J Am Optom Assoc 1980;51:761-5
77. Mathers WD, Lane JA, Zimmerman MB. Tear film changes associated with normal aging. Cornea 1996; 15:229-34
78. Patel S, Farrell J, Bevan R. Relation between precorneal tear film stability and tear production rate in normal eyes. Optom Vis Sci 1989;66:300-3
79. Damato BE, Allan D, Murray SB, Lee WR. Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol 1984;68:674-80
80. Obata H, Yamamoto S, Horiuchi H, Machinami R. Histopathologic study of human lacrimal gland. Statistical analysis with special reference to aging. Ophthalmology 1995; 102:678-86
81. Bertinotti L, Pietrini U, Del Rosso A, et al. The use of pupillometry in joint and connective tissue diseases. Ann N Y Acad Sci 2002; 966:446-55
82. Barendregt PJ, van der Heijde GL, Breedweld FC, Markusse HM. Parasympathetic dysfunction in rheumatoid arthritis patients with ocular dryness. Ann Rheum Dis 1996; 55:612-5
83. Mackie IA. Neuroparalytic (neurotrophic) keratitis, in Symposium on contact lenses. Transactions of the New Orleans Academy of Ophthalmology, St. Louis, CV Mosby, 1973
84. Mackie IA. Role of the corneal nerves in destructive disease of the cornea. Trans Ophthalmol Soc UK 1978; 98:343-7
85. Cochet P, Bonnet R. L'Esthesie corneenne. La Clin. Ophthalmol 1960; 4:3-27
86. Murphy PJ, Lawrenson JG, Patel S, Marshall J. Reliability of the non-contact corneal aesthesiometer and its comparison with the Coche-Bonnet aesthesiometer. Ophthalmic Physiol Opt 1998;18:532-9
87. Belmonte C, Acosta MC, Schmelz M, Gallar JM. Measurement of corneal sensitivity to mechanical and chemical stimulation with a CO2 esthesiometer. Invest Ophthalmol Vis Sci 1999;40:513-9
88. Feng Y, Simpson TL. Nociceptive sensation and sensitivity evoked from human cornea and conjunctiva stimulated by CO2. Invest Ophthalmol Vis Sci 2003;44:529-32
89. Morishige N., Komatsubara T, Chikama T, Nishida T. Direct observation of corneal nerve fibers in neurotrophic keratopathy by confocal biomicroscopy. Lancet 1999;354:1613-4. Comment on: Lancet 1998; 351:1783-4
90. Kallinikos P, Berhanu M, O'Donnell C, et al. Corneal nerve tortuosity in diabetic patients with neuropathy. Invest Ophthalmol Vis Sci 2004;45:418-22
91. Lee BH, McLaren JW, Erie JC. Reinnervation in the cornea after LASIK. Invest Ophthalmol Vis Sci 2002;43:3660-4
92. Patel SV, McLaren JW, Hodge DO, Bourne WM. Confocal microscopy in vivo in corneas of long-term contact lens wearers. Invest Ophthalmol Vis Sci 2002;43:995-1003
93. Daniele S, Gilbard JP, Schepens CL. Treatment of persistent epithelial defects in neurotrophic keratitis with epidermal growth factor: a preliminary open study. Graefes Arch Clin Exp Ophthalmol 1992;230:314-7
94. Lambiase A, Manni L, Rama P, Bonini S. Clinical application of nerve growth factor on human corneal ulcer. Arch Ital Biol 2003;141(2-3):141-8
95. Bonini S, Lambiase A, Rama P, et al. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 2000;107:1347-51
96. Baum J. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. Surv Ophthalmol 1999;43:372-3
97. Chikama T, Fukuda K, Morishige N, Nishida T. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I. Lancet 1998;351(9118):1783-4
98. Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998;338:1174-80
99. Brown SM, Lamberts DW, Reid TW, et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor I. Arch Ophthalmol 1997;115:926-7
100. Nishida T, Nakamura M, Konma T, et al. [Neurotrophic keratopathy - studies on substance P and the clinical significance of corneal sensation]. Nippon Ganka Gakkai Zasshi - Acta Societatis Ophthalmologicae Japonicae 1997;101:948-74
101. Fox R, Chan R, Michelson J,et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984;27:459-61
102. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent epithelial defect by autologous serum application. Ophthalmology 1999;106:1984-9
103. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999;83:390-5
104. Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eye drops for the treatment of severe dry eyes in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003;31:579-83
105. Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 2001;20:807-10
106. Tananuvant N, Daniell M, Sullivan LJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001;20:802-6
107. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004; 111(6):1115-20
108. Dufour R, Rosselet E. [The treatment of neuroparalytic keratitis]. Confin Neurol 1953;13:183-7
109. Petersen RA, Lee KS, Donn A. Acetylcholinesterase in the rabbit cornea. Arch Ophthalmol 1965;73:370-7
110. Williams JD, Cooper JR. Acetylcholine in bovine corneal epithelium. Biochem Pharmacol 1965;14:1286-9
111. Cavanagh HD, Colley AM. Cholinergic, adrenergic, and PGE1 effects on cyclic nucleotides and growth in cultured corneal epithelium. Metab Pediatr Syst Ophthalmol 1982;6:63-74
112. Colley AM, Cavanagh HD, Drake LA, Law ML. Cyclic nucleotides in muscarinic regulation of DNA and RNA polymerase activity in cultured corneal epithelial cells of the rabbit. Curr Eye Res 1985; 4:941-50
113. Cavanagh HD. Herpetic ocular disease: therapy of persistent epithelial defects. Int Ophthalmol Clin 1975 Winter;15:67-88
114. Er H. The effect of topical parasympathomimetics on corneal epithelial healing in rabbits. Doc Ophthalmol 1998;93:327-35
115. Robin JB, Kash RL, Azen SP, Schanzlin DJ. Lack of effect of pilocarpine on corneal epithelial wound healing. Curr Eye Res 1984; 3:403-6
116. Ralph RA. Tetracyclines and the treatment of corneal stromal ulceration, a review Cornea 2000;19:274-7
117. Sorsa T, Ingman T, Suomalainen K, et al. Cellular source and tetracycline-inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellims. J Clin Periodontal 1992; 19:146-9
118. Suomalainen K, Sorsa T, Ingman T, et al. Tetracycline inhibition identifies the cellular origin of interstitial collagenases in human periodontal diseases in vivo. Oral Microbiol Immunol 1992;7:121-3
119. Nip LH, Uitto VJ, Golub LM. Inhibition of epithelial cell matrix metalloproteinases by tetracyclines. J Periodontal Res 1993;28:379-85
120. Baxter SA, Laibson PR. Punctal plugs in the management of dry eyes. The Ocular Surface 2004;2:255-66
121. Tai MC, Cosar CB, Cohen EJ, et al. The clinical efficacy of silicone punctal plug therapy Cornea 2002; 21:135-9
122. Hart DE, Simko M, Harris E. How to produce moisture chamber eyeglasses for the dry eye patient. J Am Optom Assoc 1994;65:517-22
123. Koroloff N, Boots R, Lipman J, A randomised controlled study of the efficacy of hypromellose and Lacri-Lube combination versus polyethylene/cling wrap to prevent corneal epithelial breakdown in the semiconscious intensive care patient. Intensive Care Med 2004;30:1122-6
124. Kirkness CM, Adams GG, Dilly PN, Lee JP. Botulinum toxin a induced protective ptosis in corneal disease. Ophthalmology 1988;95:473-80
125. Gusek-Schneider GC, Erbguth F. [Protective ptosis by botulinum A toxin injection in corneal affectations]. Klin Monatsbl Augenheilkd 1998;213:15-22
126. Karlgard CC, Jones LW, Moresoli C. Survey of bandage lens use in North America, October-December 2002. Eye Contact Lens 2004;30:25-30
127. Kanpolat A, Ucakhan OO. Therapeutic use of Focus Night & Day contact lenses. Cornea 2003;22:726-34
128. Rosenthal P, Cotter J. The Boston scleral lens in the management of severe ocular surface disease. Ophthalmol Clin North Am 2003;16:89-93
129. Kruse FE, Rohrschneider K, Volcker HE. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 1999;106:1504-10
130. Dekaris I, Gabric N, Mravicic I, et al. Multilayer vs monolayer amniotic membrane transplantation for deep corneal ulcer treatment. Coll Antropol 2001;25 Suppl:23-8
131. Ivekovic B, Tedeschi-Reiner E, Petric I, et al. Amniotic membrane transplantation for ocular surface reconstruction in neurotrophic corneal ulcera. Coll Antropol 2002;26:47-54
132. Prabhasawat P, Tesavibul N, Komolsuradej W, et al. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br J Ophthalmol 2001;85:1455-63
133. Chen HJ, Pires RT, Tseng SC. Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br J Ophthalmol 2000; 84:826-33
134. Gris O, Wolley-Dod C, Guell JL, et al. Histologic findings after amniotic membrane graft in the human cornea. Ophthalmology 2002; 109(3):508-12
135. Scholer. Jahresberichte uber die Wirksamkeit der AugenKlinik, in den Jahren 1874-80, Berlin, H. Peters, 1875-81
136. Gundersen T. Conjunctival flaps in the treatment of corneal disease with reference to a newe technique of application. Arch Ophthalmol 1958;60:880-8
137. Alino AM, Perry HD, Kanellopoulos AJ, et al. Conjunctival flaps. Ophthalmology 1998;105:1120-3
138. Lesher MP, Lohman LE, Yeakley W, Lass J. Recurrence of herpetic stromal keratitis after a conjunctival flap surgical procedure. Am J Ophthalmol 1992;114:231-3
139. Rosenfeld SI, Alfonso EC, Gollamudi S. Recurrent herpes simplex infection in a conjunctival flap. Am J Ophthalmol 1993;116:242-4
140. Lugo M, Arentsen JJ. Treatment of neurotrophic ulcers with conjunctival flaps. Am J Ophthalmol 1987;103:711-2
141. Vote BJ, Elder MJ. Cyanoacrylate glue for corneal perforations: a description of a surgical technique and a review of the literature. Clin Experiment Ophthalmol 2000;28:437-42
142. Sharma A, Kaur R, Kumar S, et al. Fibrin glue versus N-butyl-2-cyanoacrylate in corneal perforations. Ophthalmology 2003;110:291-8
143. Kobayashi A, Shirao Y, Segawa Y, et al. Temporary use of a customized, glued-on hard contact lens before penetrating keratoplasty for descemetocele or corneal perforation. Ophthalmic Surg Lasers Imaging 2003;34:226-9
144. Diaz-Valle D, Benitez del Castillo Sanchez JM, Diaz Rodriguez E, et al. [Neurotrophic keratopathy management with cyanoacrylate tarsorrhaphy and autologous serum]. Arch Soc Esp Oftalmol 2003; 78(2):119-22
145. Sivasubramaniam P. Mode of action of tarsorrhaphy in neuroparalytic keratitis. Br J Ophthalmol 1958;42:483-5
146. Cosar CB, Cohen EJ, Rapuano CJ, et al. Tarsorrhaphy: clinical experience from a cornea practice. Cornea 2001;20:787-91
147. Reed JW, Joyner SJ, Knauer WJ 3rd. Penetrating keratoplasty for herpes zoster keratopathy. Am J Ophthalmol 1989;107:257-61
148. Soong HK, Schwartz AE, Meyer RF, Sugar A. Penetrating keratoplasty for corneal scarring due to herpes zoster ophthalmicus. Br J Ophthalmol 1989;73:19-21
149. Marsh RJ, Cooper M. Ocular surgery in ophthalmic zoster. Eye 1989; 3 (Part 3):313-7
150. Tanure MA, Cohen EJ, Grewal S, et al. Penetrating keratoplasty for varicella-zoster virus keratopathy. Cornea 2000;19:135-9